200 related articles for article (PubMed ID: 7459369)
21. Nucleoside conjugates. 10. Synthesis and antitumor activity of 1-beta-D-arabinofuranosylcytosine 5'-diphosphate-1,2-dipalmitins.
Hong CI; An SH; Schliselfeld L; Buchheit DJ; Nechaev A; Kirisits AJ; West CR
J Med Chem; 1988 Sep; 31(9):1793-8. PubMed ID: 3411602
[TBL] [Abstract][Full Text] [Related]
22. Nucleoside conjugates. 11. Synthesis and antitumor activity of 1-beta-D-arabinofuranosylcytosine and cytidine conjugates of thioether lipids.
Hong CI; Kirisits AJ; Nechaev A; Buchheit DJ; West CR
J Med Chem; 1990 May; 33(5):1380-6. PubMed ID: 2329558
[TBL] [Abstract][Full Text] [Related]
23. Schedule-dependent synergy and antagonism between high-dose 1-beta-D-arabinofuranosylcytosine and asparaginase in the L5178Y murine leukemia.
Schwartz SA; Morgenstern B; Capizzi RL
Cancer Res; 1982 Jun; 42(6):2191-7. PubMed ID: 7074600
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of the conjugate between N4-(4-carboxybutyryl)-1-beta-D-arabinofuranosylcytosine and chitosan as a macromolecular prodrug of 1-beta-D-arabinofuranosylcytosine.
Ichikawa H; Onishi H; Takahata T; Machida Y; Nagai T
Drug Des Discov; 1993; 10(4):343-53. PubMed ID: 8148473
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of antitumor activity of 1-beta-D-arabinofuranosyl-2-amino-1,4(2H)-4-iminopyrimidine in murine tumors.
Furusawa S; Mian AM
Cancer Treat Rep; 1987 May; 71(5):441-6. PubMed ID: 3567967
[TBL] [Abstract][Full Text] [Related]
26. Determination of drug synergism between the tyrosine kinase inhibitors NSC 680410 (adaphostin) and/or STI571 (imatinib mesylate, Gleevec) with cytotoxic drugs against human leukemia cell lines.
Avramis IA; Laug WE; Sausville EA; Avramis VI
Cancer Chemother Pharmacol; 2003 Oct; 52(4):307-18. PubMed ID: 12827297
[TBL] [Abstract][Full Text] [Related]
27. Analysis of the prolonged infusion of DFP-10917, a deoxycytidine analog, as a therapeutic strategy for the treatment of human tumor xenografts in vivo.
Iizuka K; Zhang C; Eshima K; Jin C; Eshima K; Fukushima M
Int J Oncol; 2018 Mar; 52(3):851-860. PubMed ID: 29344636
[TBL] [Abstract][Full Text] [Related]
28. Lack of in vivo cross-resistance with 4'-thio-ara-C against drug-resistant murine P388 and L1210 leukemias.
Waud WR; Gilbert KS; Secrist JA
Cancer Chemother Pharmacol; 2011 Aug; 68(2):399-403. PubMed ID: 21069340
[TBL] [Abstract][Full Text] [Related]
29. Metabolism and therapeutic efficacy of 9-beta-D-arabinofuranosyl-2-fluoroadenine against murine leukemia P388.
Avramis VI; Plunkett W
Cancer Res; 1982 Jul; 42(7):2587-91. PubMed ID: 7083151
[TBL] [Abstract][Full Text] [Related]
30. Effect of homoharringtonine on the viability of murine leukemia P388 cells resistant to either adriamycin, vincristine, or 1-beta-D-arabinofuranosylcytosine.
Wilkoff LJ; Dulmadge DA; Laster WR; Griswold DP
Cancer Chemother Pharmacol; 1989; 23(3):145-50. PubMed ID: 2924372
[TBL] [Abstract][Full Text] [Related]
31. Isolation and characterization of the liponucleotides of Saccharomyces cerevisiae.
Schneider EG; Kennedy EP
Biochim Biophys Acta; 1976 Aug; 441(2):294-301. PubMed ID: 782535
[TBL] [Abstract][Full Text] [Related]
32. [Antitumor effects of Behenoyl-ara-C (BH-AC) in combination with Idarubicin (IDA) in P 388 leukemic cell bearing mice].
Watanabe A; Kuriyama H; Kiyota T
Gan To Kagaku Ryoho; 1996 Feb; 23(3):291-6. PubMed ID: 8712821
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of 2,2'-anhydro-1-(3'-Ok-acetyl-beta-D-arabinofuranosyl)-5-iodocytosine hydrochloride and related compounds as antineoplastic and antiviral agents.
Itoh YH; Chu MY; Chang PK; Allaudeen HS; Sartorelli AC
Chem Biol Interact; 1981 Jan; 33(2-3):215-27. PubMed ID: 6257405
[TBL] [Abstract][Full Text] [Related]
34. Physical properties of arabinofuranosylcytosine diphosphate diacylglycerol, an antitumor liponucleotide.
Yang VC; Turcotte JG; Steim JM
Biochim Biophys Acta; 1982 Jul; 689(2):375-84. PubMed ID: 7115716
[TBL] [Abstract][Full Text] [Related]
35. 1-beta-D-arabinofuranosylcytosine conjugates of corticosteroids as potential antitumor agents.
Hong CI; Nechaev A; Kirisits AJ; Buchheit DJ; West CR
Eur J Cancer Clin Oncol; 1983 Aug; 19(8):1105-12. PubMed ID: 6684555
[TBL] [Abstract][Full Text] [Related]
36. Lipophilic 5'-(alkyl phosphate) esters of 1-beta-D-arabinofuranosylcytosine and its N4-acyl and 2,2'-anhydro-3'-O-acyl derivatives as potential prodrugs.
Rosowsky A; Kim SH; Ross J; Wick MM
J Med Chem; 1982 Feb; 25(2):171-8. PubMed ID: 7057424
[TBL] [Abstract][Full Text] [Related]
37. Effect of uracil arabinoside on metabolism and cytotoxicity of cytosine arabinoside in L5178Y murine leukemia.
Yang JL; Cheng EH; Capizzi RL; Cheng YC; Kute T
J Clin Invest; 1985 Jan; 75(1):141-6. PubMed ID: 4038404
[TBL] [Abstract][Full Text] [Related]
38. Cellular pharmacology of a liposomal preparation of N4-hexadecyl-1-beta-D-arabinofuranosylcytosine, a lipophilic derivative of 1-beta-D-arabinofuranosylcytosine.
Horber DH; Schott H; Schwendener RA
Br J Cancer; 1995 May; 71(5):957-62. PubMed ID: 7734320
[TBL] [Abstract][Full Text] [Related]
39. Membrane transport of 1-beta-D-arabinofuranosylcytosine and accumulation of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate in P388 murine leukemic cells resistant to vincristine.
Higashigawa M; Ido M; Kuwabara H; Hori H; Ohkubo T; Kawasaki H; Sakurai M; Taniguchi K; Hamazaki M
Leuk Res; 1991; 15(4):255-62. PubMed ID: 2030607
[TBL] [Abstract][Full Text] [Related]
40. Effects of naringin on cytosine arabinoside (Ara-C)-induced cytotoxicity and apoptosis in P388 cells.
Kanno S; Shouji A; Hirata R; Asou K; Ishikawa M
Life Sci; 2004 Jun; 75(3):353-65. PubMed ID: 15135655
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]